BACKGROUND: Identifying neurocognitive subtypes in schizophrenia may help establish neurobiologically meaningful subtypes of the disorder, but is frequently confounded by differences in intellectual function between individuals with schizophrenia and controls. AIMS: To examine neuropsychological performance in individuals with epidemiologically based, first-onset schizophrenia and intellectually matched controls. METHOD: Using standard IQ and reading tests, we examined the proportions of 101 people with epidemiologically derived, first-onset schizophrenia/schizoaffective disorder and 317 community controls, falling into three a priori defined intellectual categories: 'stable good', 'deteriorated poor' and 'stable poor'. Neuropsychological function was compared between intellectually matched participants with schizophrenia and control subgroups. RESULTS: Multiple deficits in executive function, processing speed and verbal memory, but not visual/spatial perception/memory, were detected in all participant groups with schizophrenia compared with controls. The average effect size across the affected domains ranged from small to medium to large in the stable good, deteriorated poor and stable poor subgroups of participants with schizophrenia, respectively. CONCLUSIONS: Compared with intellectually matched controls, people with epidemiologically derived, first-onset schizophrenia/schizoaffective disorder show multiple deficits in executive function, processing speed and verbal memory.
BACKGROUND: Identifying neurocognitive subtypes in schizophrenia may help establish neurobiologically meaningful subtypes of the disorder, but is frequently confounded by differences in intellectual function between individuals with schizophrenia and controls. AIMS: To examine neuropsychological performance in individuals with epidemiologically based, first-onset schizophrenia and intellectually matched controls. METHOD: Using standard IQ and reading tests, we examined the proportions of 101 people with epidemiologically derived, first-onset schizophrenia/schizoaffective disorder and 317 community controls, falling into three a priori defined intellectual categories: 'stable good', 'deteriorated poor' and 'stable poor'. Neuropsychological function was compared between intellectually matched participants with schizophrenia and control subgroups. RESULTS:Multiple deficits in executive function, processing speed and verbal memory, but not visual/spatial perception/memory, were detected in all participant groups with schizophrenia compared with controls. The average effect size across the affected domains ranged from small to medium to large in the stable good, deteriorated poor and stable poor subgroups of participants with schizophrenia, respectively. CONCLUSIONS: Compared with intellectually matched controls, people with epidemiologically derived, first-onset schizophrenia/schizoaffective disorder show multiple deficits in executive function, processing speed and verbal memory.
Authors: Abdalla Bowirrat; Thomas J H Chen; Marlene Oscar-Berman; Margaret Madigan; Amanda Lh Chen; John A Bailey; Eric R Braverman; Mallory Kerner; John Giordano; Siobhan Morse; B William Downs; Roger L Waite; Frank Fornari; Zaher Armaly; Kenneth Blum Journal: Mol Neurobiol Date: 2012-02-28 Impact factor: 5.590
Authors: Corby L Dale; Ethan G Brown; Alexander B Herman; Leighton B N Hinkley; Karuna Subramaniam; Melissa Fisher; Sophia Vinogradov; Srikantan S Nagarajan Journal: Schizophr Res Date: 2019-10-21 Impact factor: 4.939
Authors: Nadine Revheim; Cheryl M Corcoran; Elisa Dias; Esther Hellmann; Antigona Martinez; Pamela D Butler; Jonathan M Lehrfeld; Joanna DiCostanzo; Jennifer Albert; Daniel C Javitt Journal: Am J Psychiatry Date: 2014-09 Impact factor: 18.112
Authors: Edward Millgate; Eugenia Kravariti; Alice Egerton; Oliver D Howes; Robin M Murray; Laura Kassoumeri; Jacek Donocik; Shôn Lewis; Richard Drake; Stephen Lawrie; Anna Murphy; Tracy Collier; Jane Lees; Charlotte Stockton-Powdrell; James Walters; Bill Deakin; James MacCabe Journal: BMJ Open Date: 2021-11-25 Impact factor: 2.692
Authors: Eugenia Kravariti; Arsime Demjaha; Jolanta Zanelli; Fowzia Ibrahim; Catherine Wise; James H MacCabe; Abraham Reichenberg; Izabela Pilecka; Kevin Morgan; Paul Fearon; Craig Morgan; Gillian A Doody; Kim Donoghue; Peter B Jones; Anil Şafak Kaçar; Paola Dazzan; Julia Lappin; Robin M Murray Journal: Psychol Med Date: 2018-10-23 Impact factor: 10.592